Transcatheter Valve-in-Valve Implantation in a Stenosed Bioprosthetic Tricuspid Valve: A Case Report

2016 ◽  
Vol 25 ◽  
pp. S205
Author(s):  
R. Markham ◽  
A. Challa ◽  
S. Kyranis ◽  
N. Gaikwad ◽  
E. Shaw ◽  
...  
2021 ◽  
Vol 8 ◽  
Author(s):  
Alfredo Giuseppe Cerillo ◽  
Matteo Pennesi ◽  
Luisa Iannone ◽  
Giorgia Giustini ◽  
Paolo de Cillis ◽  
...  

We present the case of a severely symptomatic patient with a malfunctioning aortic bioprosthesis and severe multidistrict atherosclerosis that was addressed to our unit for transcatheter valve-in-valve implantation. The imaging and clinical assessment that led to the selection of the access route is discussed.


2014 ◽  
Vol 41 (5) ◽  
pp. 507-510 ◽  
Author(s):  
Ali Mortazavi ◽  
Ross M. Reul ◽  
Leon Cannizzaro ◽  
Kathryn G. Dougherty

We describe the case of a 38-year-old man with a history of metastatic testicular cancer who had undergone multiple thoracic surgical procedures, including tricuspid valve replacement with a bioprosthetic valve as a result of tricuspid involvement of his malignancy. He presented at our outpatient cardiology clinic with worsening fatigue, shortness of breath, and peripheral edema, investigation of which revealed severe tricuspid bioprosthesis stenosis with central regurgitation. Because of the patient's medical history, he was considered to be a high-risk surgical candidate. Therefore, transcatheter tricuspid valve-in-valve implantation of a 26-mm Edwards Sapien® valve was attempted through a transjugular approach. The procedure restored tricuspid valvar competence and substantially improved the patient's symptoms. We discuss the technical aspects of this case and briefly review the usefulness of the valve-in-valve technique in the tricuspid position.


Circulation ◽  
2011 ◽  
Vol 123 (5) ◽  
Author(s):  
Leen A.F.M. Van Garsse ◽  
Rachel M.A. ter Bekke ◽  
Vincent G.V.A. van Ommen

2014 ◽  
Vol 41 (5) ◽  
pp. 511-513 ◽  
Author(s):  
David M. Filsoof ◽  
David F. Snipelisky ◽  
Brian P. Shapiro

Bioprosthetic heart valves can degenerate and fail over time. Repeat surgery as a means of replacement increases morbidity and mortality rates, and some patients are not candidates for reoperation. A newer treatment, percutaneous transcatheter valve-in-valve implantation, might delay or substitute for invasive procedures. We present the case of a 51-year-old woman, a poor candidate for surgery who had prosthetic tricuspid valve degeneration and stenosis. We successfully performed valve-in-valve placement of a Melody® valve, using a procedure originally intended to treat pulmonary valve conduit obstruction or regurgitation. To our knowledge, this is among the first case reports to describe the use of the Melody pulmonary valve in transcatheter valve-in-valve replacement for prosthetic tricuspid stenosis that was otherwise not correctable. Additional data and longer follow-up periods are necessary to gain an understanding of ideal indications and selection of patients for the percutaneous transcatheter treatment of tricuspid valve stenosis.


2019 ◽  
Vol 60 (3) ◽  
pp. 198-201 ◽  
Author(s):  
V. Voudris ◽  
E. Kosmas ◽  
M. Balanika ◽  
D. Tsiapras ◽  
I. Iakovou

2015 ◽  
Vol 16 (2) ◽  
pp. 96 ◽  
Author(s):  
Ziv Beckerman ◽  
Oved Cohen ◽  
Arthur Kerner ◽  
Ariel Roguin ◽  
Avishai Ziser ◽  
...  

The strategy of transcatheter valve-in-valve implantation into failing mitral and aortic bioprosthetic valves is a documented approach. It allows one to avoid performing a high-risk repeat cardiac surgery in elderly patients with multiple comorbidities. Tricuspid valve-in-valve implantation has been documented only a few times in the literature. We report the case of a 65-year-old woman with a failing bioprosthetic tricuspid valve who had undergone 3 prior open heart operations. We attempted a transatrial transcatheter approach and successfully deployed a 29-mm Edwards Sapien balloon-expandable bioprosthesis into a severely stenotic tricuspid bioprosthesis. This case demonstrates the technical feasibility and safety of this approach.


2020 ◽  
Vol 26 (1) ◽  
pp. 135
Author(s):  
A. B. Voevodin ◽  
A. A. Allenov ◽  
V. V. Bazylev

2020 ◽  
Vol 3 (10) ◽  
pp. 01-05
Author(s):  
Marco Angelillis

Transcatheter valve in valve (ViV) implantation actually represents a valid alternative to surgical reinterventions in patients with previous surgical aortic valve replacement (AVR). In patients less than 80 years old, it is crucial to correctly position the new valve leaving a feasible and easy access to coronary ostia, both for future percutaneous coronary intervention (PCI) than for a future possible TAVinTAV procedure. We report a 71 year old man with prior AVR presented with structural valve deterioration (SVD) leading to severe aortic stenosis. In order to guarantee comfortable coronary access we aligned, the commissures of the new percutaneous valve with the ones of the surgical bioprothesis by reconstructing the headframes of the surgical bioprosthesis with computer tomography (CT) and fluoro-CT.


Sign in / Sign up

Export Citation Format

Share Document